48
Views
8
CrossRef citations to date
0
Altmetric
Review

Prospects for bioreductive drug development

Pages 905-928 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francisco J Alcaín & José M Villalba. (2007) NQO1-directed antitumour quinones. Expert Opinion on Therapeutic Patents 17:6, pages 649-665.
Read now

Articles from other publishers (7)

Michael R. Hamblin. (2018) Upconversion in photodynamic therapy: plumbing the depths. Dalton Transactions 47:26, pages 8571-8580.
Crossref
Zi-Jie Liu, Xiao-Yong Guo & Gang Liu. (2016) N-Oxide heterocycles and imidazoles replacing ring D of calanolides against Mycobacterium tuberculosis. Chinese Chemical Letters 27:1, pages 51-54.
Crossref
Vasilis P. Androutsopoulos, Athanasios Papakyriakou, Dionisios Vourloumis, Aristidis M. Tsatsakis & Demetrios A. Spandidos. (2010) Dietary flavonoids in cancer therapy and prevention: Substrates and inhibitors of cytochrome P450 CYP1 enzymes. Pharmacology & Therapeutics 126:1, pages 9-20.
Crossref
Andrew Evans, Victoria Bates, Helen Troy, Stephen Hewitt, Susan Holbeck, Yuen-Li Chung, Roger Phillips, Marion Stubbs, John Griffiths & Rachel Airley. (2007) Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemotherapy and Pharmacology 61:3, pages 377-393.
Crossref
N Chawapun. (2006) Update on clinical radiobiology. Biomedical Imaging and Intervention Journal 2:1.
Crossref
Rangaprasad Sarangarajan, Shireesh P. Apte & Sydney O. Ugwu. (2006) Hypoxia-targeted bioreductive tyrosine kinase inhibitors with glutathione-depleting function. Anti-Cancer Drugs 17:1, pages 21-24.
Crossref
Mary Hassani, Wen Cai, David C. Holley, Jayana P. Lineswala, Babu R. Maharjan, G. Reza Ebrahimian, Hassan Seradj, Mark G. Stocksdale, Farahnaz Mohammadi, Christopher C. Marvin, John M. Gerdes, Howard D. Beall & Mohammad Behforouz. (2005) Novel Lavendamycin Analogues as Antitumor Agents:  Synthesis, in Vitro Cytotoxicity, Structure−Metabolism, and Computational Molecular Modeling Studies with NAD(P)H:Quinone Oxidoreductase 1. Journal of Medicinal Chemistry 48:24, pages 7733-7749.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.